Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Breast Cancer
Interventions
PROCEDURE

Whole Body MRI

The whole body MRI will include T1-weighted and T2-weighted phase-sensitive MR imaging as well as diffusion weighted imaging of the whole body in multiple patient table stations.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Susan G. Komen Breast Cancer Foundation

OTHER

lead

M.D. Anderson Cancer Center

OTHER

NCT00592462 - Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases | Biotech Hunter | Biotech Hunter